NorthCrest Asset Manangement’s Jazz Pharmaceuticals JAZZ Stock Holding History

NorthCrest Asset Manangement’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$447K	Buy	+1,812	New	+$397K	0.01%	597

Other funds holding JAZZ

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

NorthCrest Asset Manangement's JAZZ Position: Q2 2026 in Review

NorthCrest Asset Manangement opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 1,812 shares worth $447K. The stake represents 0.01% of the portfolio and ranks #597 among its holdings.

69 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

NorthCrest Asset Manangement held 1,812 shares of Jazz Pharmaceuticals worth $447K as of Q2 2026.
Jazz Pharmaceuticals was a new NorthCrest Asset Manangement position in Q2 2026.
Jazz Pharmaceuticals made up 0.01% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #597 holding.
69 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.